| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | Burgerstein Vitamin E-
Kapseln 400 I.E. | 30 Capsule(s) | PR | 19.50 | k.A. | | | Antistress
Aktiengesellschaft für
Gesundheitsschutz | D | FB | | G |  |
| | | IP | CI | | Burgerstein Vitamin E-
Kapseln 100 I.E. | 100 Capsule(s) | PR | 24.00 | k.A. | | | Antistress
Aktiengesellschaft für
Gesundheitsschutz | D | FB | | G | |
| | | IP | CI | | Burgerstein Vitamin E-
Kapseln 400 I.E. | 100 Capsule(s) | PR | 47.00 | k.A. | | | Antistress
Aktiengesellschaft für
Gesundheitsschutz | D | FB | | G | |
| | | IP | CI | | Ephynal | 100 Capsule(s) | PR | PR | k.A. | | Capsules: Int-Rac-Alpha-Tocopherylis Acetas 300 mg | Bayer (Schweiz) AG | D | FB | | G | |
| | | IP | CI | | Evit 800 | 50 Capsule(s) | PR | PR | k.A. | | Capsules: Rrr-Alpha-Tocopherolum 536.8 mg | Doetsch Grether AG | D | FB | | G | |
| | | IP | CI | | Evit 800 | 100 Capsule(s) | PR | PR | k.A. | | Capsules: Rrr-Alpha-Tocopherolum 536.8 mg | Doetsch Grether AG | D | FB | | G | |
| | | | CI | | Phytomed Vitamin E 100 | 100 Capsule(s) | PR | PR | k.A. | | Capsules: Alpha-tocopherolum 100 mg | Phytomed AG | D | FB | | G | |
| | | | CI | | Phytomed Vitamin E 400 | 50 Capsule(s) | PR | PR | k.A. | | Capsules: Alpha-tocopherolum 400 mg | Phytomed AG | D | FB | | G | |
|
| | | IP | CI | | Ebvallo | | PR | PR | k.A. | | | Pierre Fabre Pharma SA | A | FB | | G | |
| L | | IP | | | Vegzelma 100 mg/4 ml | | 257.57 | 296.55 | 10 % | | Concentrate for infusion: Bevacizumabum 100mg / 4ml | iQone Healthcare
Switzerland SA | A / SL | FB | | G | |
| L | | IP | | | Vegzelma 400 mg/16 ml | | 962.84 | 1063.55 | 10 % | | Concentrate for infusion: Bevacizumabum 400mg / 16ml | iQone Healthcare
Switzerland SA | A / SL | FB | | G | |
| L | | IP | | PP | Herceptin subkutan
600mg/5ml | | 1484.04 | 1630.40 | 10 % | | Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | | | Ogivri 150 mg | | 456.84 | 513.25 | 10 % | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg | Medius AG | A / SL | FB | | G | |
| | | IP | CI | | Bilaxten 6 mg / ml | 5 ml | PR | PR | k.A. | | Eye drops: Bilastinum 6 mg/ml | A. Menarini GmbH | B | FB | | G | |
| | | IP | CI | | Regaine 2 % | 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 20 mg/ml | JNTL Consumer Health II
(Switzerland) GmbH | D / LPPV | FB | | G | |
| | | IP | CI | | Regaine 2 % | 3 x 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 20 mg/ml | JNTL Consumer Health II
(Switzerland) GmbH | D / LPPV | FB | | G | |
| | | IP | CI | | Regaine 5 % | 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II
(Switzerland) GmbH | D / LPPV | FB | | G | |
| | | IP | CI | | Regaine 5 % | 3 x 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II
(Switzerland) GmbH | D / LPPV | FB | | G | |
| | | IP | | | Mylotarg 5 mg | | PR | PR | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G | |
